1. A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model
   Teizo Asano et al, 2022, Antibodies CrossRef
2. Defucosylated Monoclonal Antibody (H2Mab-139-mG2a-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2
   Hiroyuki Suzuki et al, 2023, Current Issues in Molecular Biology CrossRef
3. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
   Meduri Bhagyalalitha et al, 2024, Bioorganic Chemistry CrossRef
4. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies
   Takao Arimori et al, 2024, Structure CrossRef
5. Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
   Nami Tateyama et al, 2022, Pharmaceutics CrossRef
6. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models
   Guanjie Li et al, 2023, International Journal of Molecular Medicine CrossRef